Compare NNVC & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNVC | EKSO |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7M | 7.7M |
| IPO Year | N/A | N/A |
| Metric | NNVC | EKSO |
|---|---|---|
| Price | $1.25 | $4.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | ★ 334.8K | 319.2K |
| Earning Date | 11-14-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,749,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $54.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.94 | $2.73 |
| 52 Week High | $2.23 | $14.97 |
| Indicator | NNVC | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 46.00 | 56.22 |
| Support Level | $1.23 | $4.56 |
| Resistance Level | $1.39 | $5.09 |
| Average True Range (ATR) | 0.11 | 0.39 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 42.86 | 88.05 |
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.